Effect of homocysteine on calcium mobilization and   platelet function in type 2 diabetes mellitus.
Type 2 diabetes mellitus induces a characteristic platelet hyperactivity that might be due to several factors including oxidative stress and abnormal intracellular Ca2+ homeostasis. Hyperhomocysteinaemia is considered a risk factor in the development of thrombosis although its effect on platelet function and the mechanisms involved are still poorly understood. Here we show that homocysteine (Hcy) induce a concentration-dependent increase in endogenous production of reactive oxygen species (ROS), which was significantly greater in platelets from diabetic patients than in controls. Platelet treatment with Hcy resulted in Ca2+ release from the dense tubular system and the acidic stores. Ca2+ mobilisation-induced by Hcy consisted in two components, an initial slow increase in intracellular free Ca2+ concentration ([Ca2+]i) and a rapid and marked increase in [Ca2+]i, the second leading to the activation of platelet aggregation. As well as ROS generation, Ca2+ mobilization and platelet aggregation were significantly greater in platelets from diabetic donors than in controls, which indicate that platelets from diabetic donors are more sensitive to Hcy. These findings, together with the hyperhomocysteinaemia reported in diabetic patients, strongly suggest that Hcy might be considered a risk factor in the development of cardiovascular complications associated to type 2 diabetes mellitus.
Alexandru
N
N
Institute of Cellular Biology and Pathology N. Simionescu, Bucharest, Romania.
Jardín
I
I
Popov
D
D
Simionescu
M
M
García-Estañ
J
J
Salido
G M
GM
Rosado
J A
JA
D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology*; D002118:Calcium / Q000378:metabolism*; D016022:Case-Control Studies; D048430:Cell Shape / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D005260:Female; D006262:Health; D006710:Homocysteine / Q000494:pharmacology*; D006801:Humans; D006873:Hydroquinones / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D010979:Platelet Function Tests; D017382:Reactive Oxygen Species / Q000378:metabolism; D013917:Thrombin / Q000494:pharmacology
D006873:Hydroquinones; D017382:Reactive Oxygen Species; D006710:Homocysteine; C018855:2-tert-butylhydroquinone; D013917:Thrombin; D002118:Calcium